SRPX2 and neoplasm: Given our limited cohort size, the deregulation of SRPX2 was further validated in other datasets and found that it was more highly expressed in glioblastoma tumour tissue as compared to non-tumour brain tissue according to TCGA data (Figure 4F) and in BE-GICs from the HGCC cohort (Figure 4G).